Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacek Capala

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Journal of Pharmaceutical Sciences|June 26, 2014
Polylactide-based paclitaxel-loaded nanoparticles fabricated by dispersion polymerization: characterization, evaluation in cancer cell lines, and preliminary biodistribution studiesSimeon K Adesina, Alesia Holly, Gabriela Kramer-Marek, et al.
Bioinformatics (Oxford, England)|November 6, 2009
SimBoolNet--a Cytoscape plugin for dynamic simulation of signaling networksJie Zheng, David Zhang, Pawel F Przytycki, et al.
International Journal of Radiation Biology|November 22, 2005
EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiationErika Bohl Kullberg, Qichun Wei, Jacek Capala, et al.
BMC Systems Biology|September 8, 2009
The crosstalk between EGF, IGF, and Insulin cell signaling pathways--computational and experimental analysisRafal Zielinski, Pawel F Przytycki, Jie Zheng, et al.
Seminars in Nuclear Medicine|November 30, 2010
PET/CT Imaging and Radioimmunotherapy of Prostate CancerKirsten Bouchelouche, Scott T Tagawa, Stanley J Goldsmith, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 13, 2011
68Ga-DOTA-affibody molecule for in vivo assessment of HER2/neu expression with PETGabriela Kramer-Marek, Nalini Shenoy, Jurgen Seidel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 25, 2007
[18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomographyGabriela Kramer-Marek, Dale O Kiesewetter, Lucia Martiniova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 22, 2018
Advancing Targeted Radionuclide Therapy Through the National Cancer Institute's Small Business Innovation Research PathwayKaveh Zakeri, Deepa Narayanan, Greg Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
HER2-affitoxin: a potent therapeutic agent for the treatment of HER2-overexpressing tumorsRafal Zielinski, Ilya Lyakhov, Moinuddin Hassan, et al.
Frontiers in Oncology|October 26, 2019
Clinical Outcome Assessments Toolbox for RadiopharmaceuticalsCharles A Kunos, Jacek Capala, Adam P Dicker, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Journal of Pharmaceutical Sciences|June 26, 2014
Polylactide-based paclitaxel-loaded nanoparticles fabricated by dispersion polymerization: characterization, evaluation in cancer cell lines, and preliminary biodistribution studiesSimeon K Adesina, Alesia Holly, Gabriela Kramer-Marek, et al.
Bioinformatics (Oxford, England)|November 6, 2009
SimBoolNet--a Cytoscape plugin for dynamic simulation of signaling networksJie Zheng, David Zhang, Pawel F Przytycki, et al.
International Journal of Radiation Biology|November 22, 2005
EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiationErika Bohl Kullberg, Qichun Wei, Jacek Capala, et al.
BMC Systems Biology|September 8, 2009
The crosstalk between EGF, IGF, and Insulin cell signaling pathways--computational and experimental analysisRafal Zielinski, Pawel F Przytycki, Jie Zheng, et al.
Seminars in Nuclear Medicine|November 30, 2010
PET/CT Imaging and Radioimmunotherapy of Prostate CancerKirsten Bouchelouche, Scott T Tagawa, Stanley J Goldsmith, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 13, 2011
68Ga-DOTA-affibody molecule for in vivo assessment of HER2/neu expression with PETGabriela Kramer-Marek, Nalini Shenoy, Jurgen Seidel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 25, 2007
[18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomographyGabriela Kramer-Marek, Dale O Kiesewetter, Lucia Martiniova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 22, 2018
Advancing Targeted Radionuclide Therapy Through the National Cancer Institute's Small Business Innovation Research PathwayKaveh Zakeri, Deepa Narayanan, Greg Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
HER2-affitoxin: a potent therapeutic agent for the treatment of HER2-overexpressing tumorsRafal Zielinski, Ilya Lyakhov, Moinuddin Hassan, et al.
Frontiers in Oncology|October 26, 2019
Clinical Outcome Assessments Toolbox for RadiopharmaceuticalsCharles A Kunos, Jacek Capala, Adam P Dicker, et al.
Pageof 10